Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: Evaluation of damage to nontumorous liver tissue - Long-term prospective study

Radiology

Volumn 215, Issue 1, 2000, Pages 123-128

  Caturelli, Eugenio ^a   Siena, Domenico A ^a   Fusilli, Saverio ^a   Villani, Maria Rosaria ^a   Schlavone, Giuseppe ^a   Nardella, Michele ^a   Balzano, Silverio ^a   Florio, Francesco ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Hepatic arteries, therapeutic embolization; Liver neoplasms; Liver neoplasms, chemotherapeutic infusion; Liver, cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; CHOLINESTERASE; FIBRINOGEN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FEVER; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; SCORING SYSTEM; VOMITING;

EID: 0034108780     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.215.1.r00ap21123     Document Type: Article

References (44)

1. Rustgui VK. Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am 1987; 16:545-551.
2. Muir C, Waterhouse J, Mack T, et al. Cancer incidence in five continents. Vol 5. Lyon, France: International Agency for Research on Cancer, 1987; 88.
3. Zamann SN, Johnson PJ, Williams R. Silent cirrhosis in patients with hepatocellular carcinoma. Cancer 1990; 65:1607-1610.
4. Simonetti GR, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 1997; 8:117-136.
5. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992; 15:948-955.
6. Dusheiko GM, Hobbs KEF, Dick R, Burroughs AK. Treatment of small hepatocellular carcinomas. Lancet 1992; 340:285-288.
7. Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcholic cirrhosis. Hepatology 1993; 18:47-53.
8. Adachi E, Maeda T, Matsumata T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995; 108:768-775.
9. Hatanaka Y, Yamashita Y, Takahashi M, et al. Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology 1995; 195: 747-752.
10. Levin B, Amos C. Therapy of unresectable hepatocellular carcinoma. N Engl J Med 1995; 332:1294-1296.
11. Tsuzuki T, Sugioka A, Ueda M, et al. Hepatic resection for hepatocellular carcinoma. Surgery 1990; 107:511-520.
12. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214:221-229.
13. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver transplantation versus resection for hepatocellular carcinoma in cirrhosis. Ann Surg 1993; 218:145-251.
14. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197:101-108.
15. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998; 170: 1015-1022.
16. Okada S. Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues (editorial). Hepatology 1998; 27:1743-1744.
17. Cancer Liver Italian Program (CLIP) Group. Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. Lancet 1998; 352:17-20.
18. Ryder SD, Rizzi PM, Metivier E, Karani J, Williams R. Chemoembolization with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma. Gut 1996; 38:125-128.
19. Chung JW, Park JH, Han JK, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 1996; 198:33-40.
20. Bronowicki JP, Vetter D, Dumas F, et al. Transcatheter oily Chemoembolization for hepatocellular carcinoma: a 4-year study of 127 French patients. Cancer 1994; 74: 16-24.
21. Farinati F, De Maria N, Marafin C, et al. Unresectable hepatocellular carcinoma in cirrhosis. Dig Dis Sci 1996; 14:2332-2339.
22. Liaw YF, Lin DY. Transcatheter hepatic arterial embolization in the treatment of hepatocellular carcinoma. Hepatogastroenterology 1990; 37:484-488.
23. Miyoshi S, Minami Y, Kawata S, et al. Changes in hepatic functional reserve after transcatheter embolization of hepatocellular carcinoma. J Hepatol 1988; 6:332-336.
24. Khan KN, Nakata K, Kusumoto Y, et al. Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma. Cancer Res 1991; 51:5667-5671.
25. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni ME, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
26. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 1991; 178:493-497.
27. Kan Z, Sato M, Ivancev K, et al. Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolization: experimental study in several animal species. Radiology 1993; 186:861-866.
28. Roul JL, Bourguet P, Bretagne JF, et al. Hepatic artery injection of I-131-labeled lipiodol. I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 1988; 168: 541-545.
29. Bruix J, Castells A, Montanya X, et al. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials. Hepatology 1994; 20:643-650.
30. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 1991; 68:2150-2154.
31. Bronowicki JP, Boudjema K, Chone L, et al. Comparison of resection, liver transplantation and transcatheter oily Chemoembolization in the treatment of hepatocellular carcinoma. J Hepatology 1996; 24: 293-300.
32. Lin DY, Liaw YF, Lee TY, Lai CM. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Gastroenterology 1988; 94:453-456.
33. Yamashita Y, Takahashi M, Koga Y, et al. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 1991; 67:385-391.
34. Harada T, Matsuo K, Inoue T, Tamesue S, Inoue T, Nakamura H. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 1996; 224:4-9.
35. Yu YQ, Xu DB, Zhou XD, Lu JZ, Tang ZY, Mack P. Experience with liver resection after hepatic arterial chemoembolization tor hepatocellular carcinoma. Cancer 1993; 71:62-65.
36. Bartolozzi C, Lencioni R, Caramella D, et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 1995; 197:812-818.
37. Pelletier G, Roche A, Olivier I, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990; 11:181-184.
38. Madden MV, Krige JEJ, Bailey S, et al. Randomized trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatorna. Gut 1993; 34:1598-1600.
39. Groupe D'Etude et de Traitement du Carcinome Hépatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Eng J Med 1995; 11:1256-1261.
40. Bruix J, Llovet JM, Castells A, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27:1578-1583.
41. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatmunt of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 1997; 8:117-136.
42. Kanematsu T, Matsumata T, Shirabe K, et al. A comparative study of hepatic resection and trascatheter arterial embolization for the treatment of primary hepatocellular carcinoma. Cancer 1993; 71:2181-2186.
43. Yamada R, Sato M, Kayabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148:397-401.
44. Yamashita Y, Torashima M, Oguni T, et al. Liver parenchymal changes after transcatheter arterial embolization therapy for hepatoma: CT evaluation. Abdom Imaging 1993: 18:352-356.